- Home
- PRTS vs STTK Comparison
PRTS vs STTK Comparison
Compare PRTS & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- STTK
- Stock Information
- Founded
- PRTS 1995
- STTK 2016
- Country
- PRTS United States
- STTK United States
- Employees
- PRTS N/A
- STTK 44
- Industry
- PRTS Auto & Home Supply Stores
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- STTK Health Care
- Exchange
- PRTS Nasdaq
- STTK Nasdaq
- Market Cap
- PRTS 48.0M
- STTK 48.9M
- IPO Year
- PRTS 2007
- STTK 2020
- Fundamental
- Price
- PRTS $0.74
- STTK $1.03
- Analyst Decision
- PRTS Hold
- STTK Hold
- Analyst Count
- PRTS 1
- STTK 5
- Target Price
- PRTS $0.70
- STTK $2.00
- AVG Volume (30 Days)
- PRTS 636.3K
- STTK 5.2M
- Earning Date
- PRTS 08-12-2025
- STTK 08-14-2025
- Dividend Yield
- PRTS N/A
- STTK N/A
- EPS Growth
- PRTS N/A
- STTK N/A
- EPS
- PRTS N/A
- STTK N/A
- Revenue
- PRTS $577,614,000.00
- STTK $2,997,000.00
- Revenue This Year
- PRTS $1.73
- STTK N/A
- Revenue Next Year
- PRTS $5.48
- STTK N/A
- P/E Ratio
- PRTS N/A
- STTK N/A
- Revenue Growth
- PRTS N/A
- STTK N/A
- 52 Week Low
- PRTS $0.68
- STTK $0.69
- 52 Week High
- PRTS $1.42
- STTK $3.95
- Technical
- Relative Strength Index (RSI)
- PRTS 45.40
- STTK 63.07
- Support Level
- PRTS $0.73
- STTK $0.71
- Resistance Level
- PRTS $0.94
- STTK $1.07
- Average True Range (ATR)
- PRTS 0.06
- STTK 0.10
- MACD
- PRTS -0.01
- STTK 0.03
- Stochastic Oscillator
- PRTS 23.81
- STTK 72.60
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.